REFRACTORY AML

Clinical trials for REFRACTORY AML explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY AML trials appear

Sign up with your email to follow new studies for REFRACTORY AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New hope for tough leukemia: immune cells plus targeted drug tested

Disease control Ongoing

This early-phase study tests a new treatment for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment combines specially engineered immune cells (CART123) with a targeted drug called ruxolitinib. The main goal is to see i…

Matched conditions: REFRACTORY AML

Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control

Last updated May 15, 2026 12:07 UTC

REFRACTORY AML

Get alerted when new REFRACTORY AML trials appear

New hope for tough leukemia: immune cells plus targeted drug tested